Showing 1 - 7 results of 7 for search 'Jan-Willem Alffenaar', query time: 0.03s Refine Results
  1. 1
    Cefdinir and β-Lactamase Inhibitor Independent Efficacy Against Mycobacterium tuberculosis

    Cefdinir and β-Lactamase Inhibitor Independent Efficacy Against Mycobacterium tuberculosis by Shashikant Srivastava, Shashikant Srivastava, Tania Thomas, Dave Howe, Lesibana Malinga, Prithvi Raj, Jan-Willem Alffenaar, Jan-Willem Alffenaar, Jan-Willem Alffenaar, Tawanda Gumbo, Tawanda Gumbo

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Saliva for Precision Dosing of Antifungal Drugs: Saliva Population PK Model for Voriconazole Based on a Systematic Review.

    Saliva for Precision Dosing of Antifungal Drugs: Saliva Population PK Model for Voriconazole Based on a Systematic Review. by Hannah Yejin Kim, Hannah Yejin Kim, Hannah Yejin Kim, Anne-Grete Märtson, Erwin Dreesen, Isabel Spriet, Isabel Spriet, Sebastian G. Wicha, Andrew J. McLachlan, Jan-Willem Alffenaar, Jan-Willem Alffenaar, Jan-Willem Alffenaar

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Therapeutic drug monitoring practices of anti-infectives: An Asia-wide cross-sectional survey

    Therapeutic drug monitoring practices of anti-infectives: An Asia-wide cross-sectional survey by Jingjing Hou, Jingjing Hou, Debbie Marriott, Dario Cattaneo, Sophie Stocker, Sophie Stocker, Sophie Stocker, Jana Stojanova, Jan-Willem Alffenaar, Jan-Willem Alffenaar, Jan-Willem Alffenaar, Chenlin Xiao, Chenlin Xiao, Yichang Zhao, Yichang Zhao, Hui Gong, Hui Gong, Miao Yan, Miao Yan

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis

    Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis by Haoyue Zhang, Yuying He, Lina Davies Forsman, Lina Davies Forsman, Jakob Paues, Jakob Paues, Jim Werngren, Katarina Niward, Katarina Niward, Thomas Schön, Thomas Schön, Thomas Schön, Judith Bruchfeld, Judith Bruchfeld, Jan-Willem Alffenaar, Jan-Willem Alffenaar, Jan-Willem Alffenaar, Yi Hu

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Population pharmacokinetics and model-based dosing evaluation of bedaquiline in multidrug-resistant tuberculosis patients

    Population pharmacokinetics and model-based dosing evaluation of bedaquiline in multidrug-resistant tuberculosis patients by Ge Shao, Ziwei Bao, Lina Davies Forsman, Lina Davies Forsman, Jakob Paues, Jakob Paues, Jim Werngren, Katarina Niward, Katarina Niward, Thomas Schön, Thomas Schön, Thomas Schön, Judith Bruchfeld, Judith Bruchfeld, Jan-Willem Alffenaar, Jan-Willem Alffenaar, Jan-Willem Alffenaar, Yi Hu

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    New Oxazolidinones for Tuberculosis: Are Novel Treatments on the Horizon?

    New Oxazolidinones for Tuberculosis: Are Novel Treatments on the Horizon? by Ricky Hao Chen, Andrew Burke, Jin-Gun Cho, Jan-Willem Alffenaar, Lina Davies Forsman

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Digital Health Technologies to Improve Medication Adherence and Treatment Outcomes in Patients With Tuberculosis: Systematic Review of Randomized Controlled Trials

    Digital Health Technologies to Improve Medication Adherence and Treatment Outcomes in Patients With Tuberculosis: Systematic Review of Randomized Controlled Trials by Abdurahman Ridho, Sofa D Alfian, Job F M van Boven, Jutti Levita, Esin Aki Yalcin, Ly Le, Jan-Willem Alffenaar, Eelko Hak, Rizky Abdulah, Ivan S Pradipta

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: